Chemocentryx Inc (CCXI)

$10.26 +0.06 (0.59%)
Market Cap 3.71B
Revenue (ttm) 32.22M
Net Income (ttm) -131.76M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -408.94%
Debt to Equity Ratio 0.02
Volume 12,900
Avg Vol N/A
Day's Range N/A - N/A
Shares Out 71.36M
Stochastic %K N/A
Beta 1.22
Analysts Hold
Price Target $52.00

Company Profile

Churchill Capital Corp XI does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2025 and is based in New York, New York.

Industry: Shell Companies
Sector: Financial Services
Phone: 212 380 7500
Address:
640 Fifth Avenue, 14th Floor, New York, United States
11thestate
11thestate May. 5 at 2:26 PM
$AMGN $CCXI— ChemoCentryx Agreed to Settle With Investors ChemoCentryx has agreed to settle $35 million with investors over misleading the market about avacopan, the ADVOCATE trial, and related FDA review issues. The agreement has already been submitted to the court for final approval. The settlement aims to compensate affected shareholders. If you purchased $CCXI between November 26, 2019 through May 6, 2021, you may be eligible to file a claim and recover part of your losses. You can review the details and submit your claim here:https://11th.com/cases/chemocentryx-investor-settlement
0 · Reply
WallStWireAds
WallStWireAds Apr. 9 at 11:40 AM
$ENTX New Cap Notes Report: Bones of a Bet: Why the Smart Money That Backed ChemoCentryx, Blueprint and Protagonist Just Put Its Chips on Entera Bio https://capnotes.beehiiv.com/p/bones-of-a-bet-why-the-smart-money-that-backed-chemocentryx-blueprint-and-protagonist-just-put-its-c The fund that backed ChemoCentryx ($3.7B exit), Blueprint Medicines ($9.1B exit) and Protagonist Therapeutics ($5.9B+ valuation) just invested in Entera Bio – a $54 million company developing the world’s first oral bone-building pill, with Phase 3 on the launchpad and an FDA response due in weeks. $CCXI $BPMC $PTGX $VKTX
0 · Reply
spacpack89
spacpack89 Mar. 6 at 4:38 AM
$CCXI is this a spac?
1 · Reply
UnseenProfits
UnseenProfits Feb. 4 at 3:16 PM
$CCXI is a commercial-stage biotech with a drug for a rare inflammatory disease; its commercial ramp is critical and it operates in a specialized, competitive market.
0 · Reply
Core366
Core366 Feb. 2 at 5:00 AM
$CCXI I remember this like it was yesterday. 6 months of sweating bullets after the adcom split decision. Paid off in the end with 7 figures. The last 25% additional shares I kept got bought out by amgens 3 billion aquisition
1 · Reply
nesanmano
nesanmano Jan. 14 at 1:59 PM
$CCXI I missed and even lost 1500 2000 usd because I got sold out by bank
0 · Reply
Zeyas
Zeyas Jan. 11 at 8:42 PM
$CAPR I remember $CCXI pop to +$40 on the approval and then been shorted to $15 and then climb back and bought out for $3.7b / $52 . I sold early before the bo but i will hold my shares here💎💎
1 · Reply
Luckyshann
Luckyshann Dec. 31 at 8:29 PM
$OTLK giving me flashbacks to $CCXI right before their AH approval. They got bought out shortly after for around $54 a share if I’m not mistaken
1 · Reply
Diefreeandsell
Diefreeandsell Dec. 13 at 3:40 PM
$CAPR lets discuss bo potential. when do you think it will happen and who will be the buyer? Keep in mind that In essence, the sweet spot for a biotech company is when its lead asset has demonstrated strong human efficacy data, maximizing its value to potential acquirers. By the way I was spot on when Aveo $CCXI $RXDX $CDTX where bought out. I was wrong w $TGTX but that worked out pretty good too! Most bo targets have compelling late stage trial results followed by offering after huge gap up that never closes the gap, continues to hold above the offering price and may even continue to trend up as tutes accumulate shares. Sound familiar?
5 · Reply
raticals
raticals Dec. 9 at 7:28 PM
$MLTX $CCXI charts after blowup almost identical
2 · Reply
Latest News on CCXI
Churchill Capital Corp XI Announces the Pricing of Upsized $360 Million Initial Public Offering

Dec 16, 2025, 6:59 PM EST - 5 months ago

Churchill Capital Corp XI Announces the Pricing of Upsized $360 Million Initial Public Offering

Michael Klein's SPAC Churchill Capital XI files for a $300 million IPO

Nov 18, 2025, 6:27 PM EST - 6 months ago

Michael Klein's SPAC Churchill Capital XI files for a $300 million IPO

Churchill Capital Corp XI IPO Registration Document (S-1)

Nov 18, 2025, 4:50 PM EST - 6 months ago

Churchill Capital Corp XI IPO Registration Document (S-1)

Can ChemoCentryx Control Challenging Capital Complications?

2022-05-22T08:46:43.000Z - 4 years ago

Can ChemoCentryx Control Challenging Capital Complications?

ChemoCentryx: Can Pharma Company Hit Big?

2022-01-26T15:31:20.000Z - 4 years ago

ChemoCentryx: Can Pharma Company Hit Big?

ChemoCentryx Stock Is a Highly Speculative Bet

2021-12-27T15:58:11.000Z - 4 years ago

ChemoCentryx Stock Is a Highly Speculative Bet

ChemoCentryx Q3 Results Surpass Expectations; Street Says Buy

2021-11-10T09:22:36.000Z - 4 years ago

ChemoCentryx Q3 Results Surpass Expectations; Street Says Buy

ChemoCentryx Stock: Worth Keeping an Eye on

2021-10-15T13:46:29.000Z - 4 years ago

ChemoCentryx Stock: Worth Keeping an Eye on

ChemoCentryx Receives FDA Approval for TAVNEOS; Shares Skyrocket

2021-10-11T06:23:45.000Z - 4 years ago

ChemoCentryx Receives FDA Approval for TAVNEOS; Shares Skyrocket

Chemocentryx: A Risky Yet Potentially Lucrative Bet

2021-07-09T20:31:53.000Z - 5 years ago

Chemocentryx: A Risky Yet Potentially Lucrative Bet

Is Chemocentryx Stock a Buy Right Now? This Is What You Need to Know

2021-05-10T20:31:55.000Z - 5 years ago

Is Chemocentryx Stock a Buy Right Now? This Is What You Need to Know

11thestate
11thestate May. 5 at 2:26 PM
$AMGN $CCXI— ChemoCentryx Agreed to Settle With Investors ChemoCentryx has agreed to settle $35 million with investors over misleading the market about avacopan, the ADVOCATE trial, and related FDA review issues. The agreement has already been submitted to the court for final approval. The settlement aims to compensate affected shareholders. If you purchased $CCXI between November 26, 2019 through May 6, 2021, you may be eligible to file a claim and recover part of your losses. You can review the details and submit your claim here:https://11th.com/cases/chemocentryx-investor-settlement
0 · Reply
WallStWireAds
WallStWireAds Apr. 9 at 11:40 AM
$ENTX New Cap Notes Report: Bones of a Bet: Why the Smart Money That Backed ChemoCentryx, Blueprint and Protagonist Just Put Its Chips on Entera Bio https://capnotes.beehiiv.com/p/bones-of-a-bet-why-the-smart-money-that-backed-chemocentryx-blueprint-and-protagonist-just-put-its-c The fund that backed ChemoCentryx ($3.7B exit), Blueprint Medicines ($9.1B exit) and Protagonist Therapeutics ($5.9B+ valuation) just invested in Entera Bio – a $54 million company developing the world’s first oral bone-building pill, with Phase 3 on the launchpad and an FDA response due in weeks. $CCXI $BPMC $PTGX $VKTX
0 · Reply
spacpack89
spacpack89 Mar. 6 at 4:38 AM
$CCXI is this a spac?
1 · Reply
UnseenProfits
UnseenProfits Feb. 4 at 3:16 PM
$CCXI is a commercial-stage biotech with a drug for a rare inflammatory disease; its commercial ramp is critical and it operates in a specialized, competitive market.
0 · Reply
Core366
Core366 Feb. 2 at 5:00 AM
$CCXI I remember this like it was yesterday. 6 months of sweating bullets after the adcom split decision. Paid off in the end with 7 figures. The last 25% additional shares I kept got bought out by amgens 3 billion aquisition
1 · Reply
nesanmano
nesanmano Jan. 14 at 1:59 PM
$CCXI I missed and even lost 1500 2000 usd because I got sold out by bank
0 · Reply
Zeyas
Zeyas Jan. 11 at 8:42 PM
$CAPR I remember $CCXI pop to +$40 on the approval and then been shorted to $15 and then climb back and bought out for $3.7b / $52 . I sold early before the bo but i will hold my shares here💎💎
1 · Reply
Luckyshann
Luckyshann Dec. 31 at 8:29 PM
$OTLK giving me flashbacks to $CCXI right before their AH approval. They got bought out shortly after for around $54 a share if I’m not mistaken
1 · Reply
Diefreeandsell
Diefreeandsell Dec. 13 at 3:40 PM
$CAPR lets discuss bo potential. when do you think it will happen and who will be the buyer? Keep in mind that In essence, the sweet spot for a biotech company is when its lead asset has demonstrated strong human efficacy data, maximizing its value to potential acquirers. By the way I was spot on when Aveo $CCXI $RXDX $CDTX where bought out. I was wrong w $TGTX but that worked out pretty good too! Most bo targets have compelling late stage trial results followed by offering after huge gap up that never closes the gap, continues to hold above the offering price and may even continue to trend up as tutes accumulate shares. Sound familiar?
5 · Reply
raticals
raticals Dec. 9 at 7:28 PM
$MLTX $CCXI charts after blowup almost identical
2 · Reply
Yuri911
Yuri911 Nov. 20 at 4:48 PM
$MCRB I remember $CCXI dropped just before BO, hoping for the same outcome
0 · Reply
Barkingdogs
Barkingdogs Nov. 10 at 10:36 PM
$IFRX as said before just google = "$CCXI Bought Out by Amgen for $4 billion " Then Realize IFX-1 is similar if not BETTER than CCX-168 = then A light SHOULD go off in YOUR head saying WTF is $IFRX doing at a market cap of $150M when its competitor sold for $4B ??!
0 · Reply
Mattylight1983
Mattylight1983 Nov. 8 at 9:11 AM
$CCXI watching is this bullish or rug pull and buy some puts
0 · Reply
Steve_TheBull_Rogers
Steve_TheBull_Rogers Oct. 2 at 8:56 PM
$MLTX I remember Chemocentryx as I called that BO back then. We did a 5 x ticker was $CCXI
0 · Reply
TAG01
TAG01 Sep. 29 at 3:36 PM
$CCXI well I followed Thomas Schall to IMRX.. do your own dd but phase 2 data says 86% survival of pancreatic cancer. standard of care is ~50%. just listened to PR call. 2 year investment. i believe it will dip just like ccxi did inbetween PR my load boat number us around 5 but have position at 7.75 now. glta.. i als track Jain Rita who made me money at PRVB and is now at CLDX
1 · Reply
LaMangRoLotto
LaMangRoLotto Sep. 19 at 4:04 AM
$OPEN I was in $CCXI and I always thought that was the coolest trade I’ve ever been in. We all woke up one morning PAID!!! I was down 40% at one point… That was awesome - but this feels like sooooo much more here!!! 😎
0 · Reply
nesanmano
nesanmano Sep. 17 at 1:05 PM
$CCXI where is the buyout ow. It has been sitting at 50 for more than a year
0 · Reply
JimmyBoomBoom
JimmyBoomBoom Sep. 14 at 5:41 PM
Look to see where there is unmet need. Saw steroid-free alternatives for autoimmune diseases ($CCXI) and COPD ($VRNA). Huge unmet need for metabolic Liver diseases ($MDGL) and Alzheimer's Disease ($AVXL) not requiring costly and inconvenient injections.
3 · Reply
2l84me1
2l84me1 Aug. 12 at 3:58 PM
$WLGS I saw something similar happen with $CCXI, small swing and day trades up until FDA approval, stock crashed to $10, 3-4 months later we 5x our money. Good news coming, lots of contracts and revenue in pipeline
1 · Reply
Rascal7777777
Rascal7777777 Aug. 12 at 2:50 PM
$CCXI what do you think about avxl?
0 · Reply
Illtbagya
Illtbagya Jul. 30 at 11:01 PM
$IXHL I want to see the halt in the morning and we open at 44. Then see we can’t do anything because company is sold like $CCXI did. I was in that and it was beautiful!
1 · Reply
MacAwoo
MacAwoo Jul. 30 at 6:26 PM
$CCXI miss you 🥺
0 · Reply